Weight gain with pizotifen therapy

Archives of Disease in Childhood

Volumn 93, Issue 7, 2008, Pages 590-593

  Briars, G L ^a   Travis, S E ^a   Anand, B ^a   Kelly, A M ^a  

^a WEST SUFFOLK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PIZOTIFEN; ANALGESIC AGENT; SEROTONIN ANTAGONIST;

ADOLESCENT; ARTICLE; BODY MASS; BODY SURFACE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT GAIN; BODY HEIGHT; CHILD; DRUG EFFECT; TREATMENT OUTCOME;

ANALGESICS, NON-NARCOTIC; BODY HEIGHT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MIGRAINE DISORDERS; PIZOTYLINE; RETROSPECTIVE STUDIES; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 48949119135     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.128611     Document Type: Article

References (16)

1. Muszkat M, Vergani Ml, Torres DM. Headache in childhood: diagnosis and therapy. A prospective study of 77 cases. Arq Neuropsiquiatr 1988;46:254-7.
2. Del Bene E, Poggioni M, Michelacci S. Lisuride as a migraine prophylactic in children: an open clinical trial. Int J Clin Pharmacol Res 1983;3:137-41.
3. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child 1995;72:48-50.
4. Salmon MA, Walters DD. Pizotifen in the prophylaxis of cyclical vomiting. Lancet 1985;1:1036-7.
5. Fall M, Sarr M, Sail MG, et al. BC 105 in the Pediatric Service of the University Hospital Center of Dakar in protein-calorie malnutrition in children. Dakar Med 1982;27:537-44.
6. Dolecek R, Janstova V. Long-term effect of pizotifen treatment on growth hormone levels of underweight children, including those with anorexia nervosa. Pharmatherapeutica 1985;4:81-7.
7. Leysen JE. 5-HT2 receptors. Curr Drug Targets CNS Neurol Dis 2004;3(1):11-26.
8. Halford JCG, Wanninayake SCD, Blundell JE. Behavioural satiety sequence for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 1998;61:159-68.
9. Winner P, Martinez W, Mate L, et al. Classification of pediatric migraine: proposed revisions to the IHS criteria. Headache 1995;35:407-10.
10. Li BU, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a braingut disorder. Adv Pediatr 2000;47:117-60.
11. Bailey BJ, Briars GL Estimating the surface area of the human body. Stat Med 1996;15:1325-32.
12. Humphrey PP, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 1993;14(6):233-6.
13. Tecott LH, Sum LM, Akana SF. Eating disorder and epilepsy in mice lacking 5HT2c serotonin receptors. Nature 1995;374:542-6.
14. Lentes KU, Hinney A, Ziegler A, et al. Evaluation of a Cys23Ser mutation within the human 5HT2c receptor gene: no evidence for an association of the mutant allele with obesity or underweight in children, adolescents and young adults. Life Sci 1997;61:PL9-16.
15. Lopez M, Tovar S, Vazquez MJ, et al. Peripheral tissue-brain interactions in the regulation of food intake. Proc Nutr Soc 2007;66:131-55.
16. Heisler LK, Cowley MA, Kishi T, et al. Central serotonin and melanocortin pathways regulating energy homeostasis. Ann N Y Acad Sci 2003;994:169-74.